Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024

Core Insights - Alector, Inc. is presenting its TREM2 and progranulin programs at the Alzheimer's Association International Conference® 2024, highlighting its focus on immuno-neurology for treating neurodegenerative diseases [1][2]. Group 1: Alector's Programs - The TREM2 Program (AL002) is being developed in collaboration with AbbVie, with poster presentations scheduled for July 28 and July 29, 2024, focusing on early Alzheimer's disease [1]. - The Progranulin Programs (latozinemab (AL001) and AL101/GSK4527226) are being developed in collaboration with GSK, with multiple poster presentations on July 28 and July 29, 2024, addressing various aspects of Alzheimer's disease [1]. Group 2: Conference Details - The Alzheimer's Association International Conference® 2024 will be held online and in Philadelphia from July 28 to August 1, 2024, with on-demand viewing of poster presentations starting on July 28 at 8:00 a.m. ET [1].